Biosergen
0,428
SEK
+9,46 %
Mindre end 1K følgere
BIOSGN
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
+9,46%
-2,28%
-19,25%
-34,95%
-36,5%
-0,47%
-84,33%
-
-88,42%
Biosergen is a biotechnology company. The company specializes in the research and development of various pharmaceuticals. The product portfolio includes, for example, the company's product BSG005, a fungicidal pharmaceutical in the clinical phase. In addition to the main business, service and associated ancillary services are also offered. The company operates in Norway. Biosergen was founded in 2004 and is headquartered in Solna.
Læs mereMarkedsværdi
100,5 mio. SEK
Aktieomsætning
99,61 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
21.5
2025
Delårsrapport Q1'25
11.6
2025
Generalforsamling '25
20.8
2025
Delårsrapport Q2'25
ViserAlle indholdstyper
Biosergen AB: BioStock: Biosergen scales up for future wins
Biosergen AB: Biosergen publishes interim report for fourth quarter 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools